Scott A. Gangloff serves as Executive at Oncobiologics, Inc., where they oversee executive responsibilities. Since joining the company, Scott A. Gangloff has executed 8 insider transactions totaling $140.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved selling 5,088 shares valued at $0.
Scott A. Gangloff currently holds 26,351 shares of Oncobiologics, Inc. (ONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott A. Gangloff has been a net seller of ONS stock. They have purchased $0 and sold $140.1K worth of shares.
Scott A. Gangloff's most recent insider trade was on Dec 9, 2025, when they sold 5,088 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 15, 2025 | AKRO | $51.0K | Option Exercise | 2,600 | $19.62 | Discretionary |
| Jun 30, 2025 | AKRO | $7.1K | Award | 299 | $23.87 | Discretionary |
| Dec 21, 2016 | ONS | $0 | Award | 40,000 | $N/A | Discretionary |
| Nov 11, 2016 | ONS | $140.1K | Sale | 37,369 | $3.75 | Discretionary |
| Nov 9, 2016 | ONS | $0 | Conversion | 115,942 | $N/A | Discretionary |
| Nov 9, 2016 | ONS | $0 | Option Exercise | 115,942 | $N/A | Discretionary |